An Open-label Study of Xeloda Plus Avastin at Time of Disease Progression in Treatment-naive Women With HER2-negative Metastatic Breast Cancer.
Phase of Trial: Phase IV
Latest Information Update: 03 Mar 2011
At a glance
- Drugs Bevacizumab; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 21 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 21 Jul 2009 Actual number of patients (108) added as reported by ClinicalTrials.gov.
- 21 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.